343 related articles for article (PubMed ID: 36980680)
1. Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.
Motta JM; Hassan H; Ibrahim SA
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980680
[TBL] [Abstract][Full Text] [Related]
2. Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.
Agere SA; Kim EY; Akhtar N; Ahmed S
J Cell Physiol; 2018 Sep; 233(9):6346-6358. PubMed ID: 29226950
[TBL] [Abstract][Full Text] [Related]
3. Syndecans as modulators and potential pharmacological targets in cancer progression.
Barbouri D; Afratis N; Gialeli C; Vynios DH; Theocharis AD; Karamanos NK
Front Oncol; 2014; 4():4. PubMed ID: 24551591
[TBL] [Abstract][Full Text] [Related]
4. Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.
Gharbaran R
Tumour Biol; 2016 Sep; 37(9):11573-11588. PubMed ID: 27317256
[TBL] [Abstract][Full Text] [Related]
5. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
Ridgway LD; Wetzel MD; Marchetti D
J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
[TBL] [Abstract][Full Text] [Related]
6. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
9. Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
Depau L; Brunetti J; Falciani C; Mandarini E; Riolo G; Zanchi M; Karousou E; Passi A; Pini A; Bracci L
J Med Chem; 2020 Dec; 63(24):15997-16011. PubMed ID: 33284606
[TBL] [Abstract][Full Text] [Related]
10. The Laminin-
Puchalapalli M; Mu L; Edwards C; Kaplan-Singer B; Eni P; Belani K; Finkelstein D; Patel A; Sayyad M; Koblinski JE
Anal Cell Pathol (Amst); 2019; 2019():9192516. PubMed ID: 31183318
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
[TBL] [Abstract][Full Text] [Related]
12. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.
Maeda T; Alexander CM; Friedl A
Cancer Res; 2004 Jan; 64(2):612-21. PubMed ID: 14744776
[TBL] [Abstract][Full Text] [Related]
13. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
[TBL] [Abstract][Full Text] [Related]
14. Role of syndecan-4 in breast cancer pathophysiology.
Onyeisi JOS; Lopes CC; Götte M
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1345-C1354. PubMed ID: 36094435
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
16. Minireview: Syndecans and their crucial roles during tissue regeneration.
Chung H; Multhaupt HA; Oh ES; Couchman JR
FEBS Lett; 2016 Aug; 590(15):2408-17. PubMed ID: 27383370
[TBL] [Abstract][Full Text] [Related]
17. Syndecans and Enzymes for Heparan Sulfate Biosynthesis and Modification Differentially Correlate With Presence of Inflammatory Infiltrate in Periodontitis.
Duplancic R; Roguljic M; Puhar I; Vecek N; Dragun R; Vukojevic K; Saraga-Babic M; Kero D
Front Physiol; 2019; 10():1248. PubMed ID: 31611818
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
19. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]